Personalized management of cirrhosis by non-invasive tests of liver fibrosis
Clinical and Molecular Hepatology. 2015;21(3):200 
Non‐invasive evaluation of liver fibrosis: More well‐validated tests available for patient management
Liver International. 2015;35(6):1643-1645
Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis
Liver. 2000;20(3):262-266
Combination of non-invasive fibrosis tests: a solution for the prediction of advanced fibrosis in non-alcoholic fatty liver disease?
Journal of Gastrointestinal and Liver Diseases. 2019;28(3):257-259
EPS3.8 Non-invasive liver tests in cystic fibrosis-related liver disease (CFLD)
Journal of Cystic Fibrosis. 2017;16:S43
Colchicine for alcoholic and non-alcoholic liver fibrosis or cirrhosis
Liver. 2001;21(2):129-136
Can Non-Invasive Assessment of Liver Fibrosis Be Used As A Predictor of Prognosis for HCC Patients with HBV-Related Cirrhosis?
. 2020;
Non‐invasive diagnosis tests
Cirrhosis: A practical guide to management. 2015;53-62
CS17-02 Non-Invasive Assessment of Liver Fibrosis and Cirrhosis
International Journal of Infectious Diseases. 2009;13:S22
Non‐invasive tests for liver fibrosis in NAFLD: Creating pathways between primary healthcare and liver clinics
Liver International. 2020;40(S1):77-81